Antidiabetic E4orf1 protein prevents hepatic steatosis and reduces markers of aging-related cellular damage in high fat fed older mice
Introduction Older age is associated with greater prevalence of hyperinsulinemia, type 2 diabetes, and fatty liver disease. These metabolic conditions and aging are bidirectionally linked to mitochondrial dysfunction and telomere attrition. Although effectively addressing these conditions is importa...
Saved in:
| Main Authors: | Zahra Mostofinejad, Md Akheruzzaman, Md Abu Bakkar Siddik, Presheet Patkar, Nikhil V Dhurandhar, Vijay Hegde |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-03-01
|
| Series: | BMJ Open Diabetes Research & Care |
| Online Access: | https://drc.bmj.com/content/9/1/e002096.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety Assessment of a Potential Anti-diabetic Agent in a Pre-clinical Model
by: Md Abu Bakkar Siddik, et al.
Published: (2025-05-01) -
E4orf1 Enhances Glycemic Regulation, Cognitive Function, and Obesity-Linked Molecular Pathways in a Male Mouse Model of Obesity-Associated Alzheimer’s Disease
by: Vijay Hegde, et al.
Published: (2025-05-01) -
Leaf powder supplementation of Senna alexandrina ameliorates oxidative stress, inflammation, and hepatic steatosis in high-fat diet-fed obese rats.
by: Shariful Islam Nayan, et al.
Published: (2021-01-01) -
Acute and Long-Term Effects of Insparin and Pioglitazone on Tissue Distribution of Glucose Uptake
by: Sara Ranjbar, et al.
Published: (2025-05-01) -
A 70 Amino Acid Fragment of Insparin Retains Its Potential to Upregulate Distal Insulin Signaling
by: Tanvi Kale, et al.
Published: (2025-05-01)